BRIEF-Flowco Holdings Sets IPO Price Range Between $21.00 And $23.00 Per Share-March 2024-www.financetom.com

BRIEF-Flowco Holdings Sets IPO Price Range Between $21.00 And $23.00 Per Share

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Flowco Holdings Sets IPO Price Range Between $21.00 And $23.00 Per Share

Jan 7, 2025 3:57 AM

Jan 7 (Reuters) - Flowco Holdings Inc:

* FLOWCO HOLDINGS INC - IPO PRICE RANGE SET BETWEEN $21.00

AND

$23.00 PER SHARE

* FLOWCO HOLDINGS INC SEES IPO OF 17.8 MILLION CLASS A

COMMON

STOCK

* FLOWCO HOLDINGS INC: REMOVED BOFA SECURITIES FROM THE LIST

UNDERWRITERS TO IPO - SEC FILING

Source text:

Further company coverage:

Previous page： AtkinsRealis Joint Venture with Stantec to Provide Water Services in U.K. Next page： Nippon Steel Delays Closing of US Steel Deal After US Department of Justice Request

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

AtkinsRealis Joint Venture with Stantec to Provide Water Services in U.K.

May 3, 2024

08:31 AM EDT, 05/03/2024 (MT Newswires) -- AtkinsRealis (ATRL.TO) said Friday that its joint venture with Stantec ( STN ) has been appointed by Thames Water, U.K.'s largest water company, to serve customers in southeast England. The agreement is part of a technical partner framework where Thames Water will get access to professional support services worth up to 300 million...

Nippon Steel Delays Closing of US Steel Deal After US Department of Justice Request

May 3, 2024

07:45 AM EDT, 05/03/2024 (MT Newswires) -- Nippon Steel announced Friday it has pushed back the estimated closing date of its acquisition of US Steel (X) following its receipt of an additional request for information by the US Department of Justice. The company now estimates the closing date to occur in the third or fourth quarter of 2024, compared to...

AEON Biopharma Shares Slump Pre-Bell After Failed Chronic Migraine Phase 2 Trial

May 3, 2024

08:31 AM EDT, 05/03/2024 (MT Newswires) -- AEON Biopharma ( AEON ) shares tumbled more than 55% in premarket activity Friday after the company said that its preventive treatment for chronic migraine, ABP-450, did not meet the primary endpoint of its phase 2 trial. ABP-450 did not demonstrate statistically significant superiority over placebo in this interim readout, said AEON Chief...

Brookfield Business Partners Q1 Net Income, Revenue Decline

May 3, 2024

08:27 AM EDT, 05/03/2024 (MT Newswires) -- Brookfield Business Partners LP ( BBU ) reported Q1 net income Friday of $0.23 per limited partnership unit, down from $0.34 a year earlier. Revenue for the quarter ended March 31 was $12.02 billion, down from $13.76 billion a year earlier. A single analyst surveyed by Capital IQ expected $16.1 billion. ...